Market Leader NeuroStar Advanced Therapy is the market-leading TMS solution with broad US deployment and growing international reach, presenting a clear opportunity to upsell clinics on expanded NeuroStar capabilities, service, and add-on programs.

Expansion Opportunities Recent partnerships and acquisitions, including Thetmscenterofnj and Medisun, alongside planned clinics and first-line adolescent approvals, indicate a scalable growth trajectory and potential for channel partnerships, integrators, and regional healthcare networks.

Strategic Partnerships Active collaboration with clinics, centers, and med-tech ecosystems suggests selling opportunities around co-branded programs, referral networks, and bundled service agreements that enhance patient access and treatment throughput.

Clinical Adoption FDA clearance for adolescent use and the Better Me Provider program underscore demand for accessible, non-pharmacologic depression therapies, creating a path for hospital systems and outpatient networks to adopt NeuroStar as a front-line or adjacent therapy.

Financial Growth Revenue growth driven by US clinic expansion and increased NeuroStar system sales signals willingness to invest in upgrades, maintenance, and training services, offering recurring revenue via service contracts and device lifecycle management.